Related Experiment Video
Updated: Sep 26, 2025

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified
Robyn Rexwinkel1, Arine M Vlieger2, Miguel Saps3
1Emma Children's Hospital, Amsterdam UMC, Pediatric Gastroenterology, University of Amsterdam, Room C2-312, PO Box 22700, 1100 DD, Amsterdam, Netherlands. r.rexwinkel@amsterdamumc.nl.
Insights
Pediatric functional abdominal pain disorders like Irritable Bowel Syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP-NOS) require a tailored, stepwise approach. Management involves shared decision-making with families on non-pharmacological and pharmacological treatments.
Area of Science:
- Pediatric Gastroenterology
- Gut-Brain Interaction Disorders
Background:
- Irritable Bowel Syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP-NOS) are prevalent in childhood, impacting quality of life and incurring significant socioeconomic costs.
- Current management of these gut-brain interaction disorders is challenging due to a lack of high-quality intervention trials and international guidelines.
Purpose of the Study:
- To provide an updated overview of therapeutic options for pediatric IBS or FAP-NOS.
- To recommend evidence-based management strategies for these common functional abdominal pain disorders in children.
Main Methods:
- This review synthesizes current knowledge on therapeutic possibilities for pediatric IBS and FAP-NOS.
- It proposes a stepwise, individualized management approach based on patient-specific physical and psychological symptoms.
Main Results:
- A positive diagnosis of IBS or FAP-NOS with minimal investigation is crucial to prevent unnecessary referrals and costs.
- A tailor-made approach, considering both non-pharmacological and pharmacological interventions, is recommended.
Conclusions:
- Shared decision-making with families is essential for managing pediatric functional abdominal pain disorders.
- A stepwise, individualized strategy incorporating non-pharmacological and pharmacological interventions should be discussed with families.
Abstract:
Disorders of the gut-brain interaction negatively impact quality of life and carry a substantial socioeconomic burden. Irritable bowel syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP-NOS) are common functional abdominal pain disorders in childhood. The pathophysiology is not fully understood, and high-quality intervention trials and international guidelines are missing. Therefore, the management of these disorders remains challenging. This review aims to provide an up-to-date overview of therapeutic possibilities for pediatric IBS or FAP-NOS and recommends management strategies. To prevent unnecessary referrals and extensive costs, it is fundamental to make a positive diagnosis of IBS or FAP-NOS in children with chronic abdominal pain with only minimal investigations. A tailor-made approach for each patient, based on the accompanying physical and psychological symptoms, is proposed to date.
Conclusion:
Shared decision-making including non-pharmacological and pharmacological interventions should be considered and discussed with the family.
What Is Known:
• Irritable bowel syndrome and functional abdominal pain-not otherwise specified are common in childhood. • Although the number of treatment options has grown recently, managing these disorders can be challenging and unsatisfactory, and no evidence-based international management guidelines are available.
What Is New:
• We suggest using a stepwise individualized approach to management, where after first-line management, both non-pharmacological and pharmacological interventions should be discussed.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

